FEMSelect is a Woman-Led Company
As co-CEOs of FEMSelect, Debbie and Renee both have a deep understanding of the debilitating symptoms and emotional strains caused by prolapse. Over their careers, both have been committed to women’s health and are leading together to develop innovative and safe solutions for women.
Sasha Schrode
CEO
Sasha Schrode is the CEO of FEMSelect and a member of the company’s board of directors. Sasha brings over 20 years of experience in healthcare where she has focused on addressing the needs of the evolving healthcare landscape by driving improvements to patient outcomes and increasing healthcare economic efficiency. Prior to joining FEMSelect, she founded Serpex Medical, a MedTech company that was acquired in 2023. Under her leadership, she has brought transformational MedTech innovations to market while creating value to shareholders.
Sasha is also a Partner at Robin Hood Ventures and serves on the board of FEMSelect, The American Lung Association, Cooler Heads, University of Penn’s Health Technology and is an advisor to FloBio and RTM Vital Signs. She has a B.A in Business Administration and a M.B.A in Finance and Healthcare Administration. Sasha is passionate about advancing women’s health and leveraging her expertise to deliver impactful solutions worldwide.
Debbie Garner
President
Debbie has 20 years of experience in commercialization leadership roles. She has launched and built the market for innovative women’s health care products with Eli Lilly and Co. and iMDsoft in numerous international markets. Debbie holds an MBA from the Wharton School of Business of the University of Pennsylvania and a BA from Harvard College.
Joel Chechik
Chief Commercial Officer
Joel brings 20+ years of Sales and Marketing leadership to FEMSelect, having served in sales leadership roles with Coloplast, Medtronic and NeoTract. He has led targeted marketing and sales expansion initiatives driving adoption of minimally invasive, cardiac and urologic implantable technologies. Joel is a hands-on US-based sales leader who can show a sales team how to work with key opinion leader physicians who need to learn and become confident with a new procedure, before recommending that procedure to patients and to colleagues in their practice and medical center.
Karla Loken DO ObGyn FACOOG
Chief Medical Officer US
Dr Loken brings years of experience in Medical Affairs for several global therapeutics and medical device companies as well as 20+ years of women’s health experience in private practice, medical education and academics – which have prepared her to drive adoption of this innovative new approach to treating Pelvic Organ Prolapse.
Prof. Menahem Neuman
Founder & Medical Director
Menahem is currently Head of Urogynecology, Galilee Medical Center and Bar-Ilan University. Prior to this, he was Ethicon Women’s Health & Urology PFR global trainer and Pelvic Floor Innovation Committee Member.
Boaz Harari
Founder VP Research & Development
Boaz has over 20 years of experience in the medical device field. Former CTO of VibeMedic Ltd. and Niti Surgical Solutions Ltd. He is an experienced engineer who has developed numerous clinical devices from concept to market.
Sherwyn Davidson
VP Quality and Regulatory Affairs
Sherwyn is an experienced medical device Quality Management and Regulatory professional. He has over 20 years of experience interacting with regulatory authorities and establishing and maintaining a Quality Management System with more than 10 years as Senior Project Manager at Medicsense Ltd., a leading Israeli consulting firm. Sherwyn holds a B.Sc. in Industrial Engineering from Ben-Gurion University.
